Drug companies like Eli Lilly and Roche are racing to build supercomputers to help fix the 90% failure rate in drug ...

This week, the California Supreme Court is set to hear a case that could have far-reaching consequences for medical science.

Drug discovery still too often relies on expensive trial and error. Researchers from ICTER show there is another way—building ...

By Michael Erman NEW YORK, April 27 (Reuters) - Johnson & Johnson is using artificial intelligence to slash by half the time ...

Wanted: a cheap, multipotent treatment for viral infections. Must be able to handle new or unfamiliar strains, or (even ...

The European Medicines Agency (EMA) on Monday launched a public consultation on revised guidance for companies developing new drugs to treat tuberculosis (TB). Comments on the guidance, which is an ...

TAIPEI, March 5, 2026 /PRNewswire/ -- Great Novel Therapeutics Biotech & Medicals Corporation (GNTbm) (stock code: 7427) announced that its independently developed novel epigenetic immunoactivator ...

SHELTON, CT / ACCESS Newswire / May 4, 2026 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the ...

Two-thirds of all new drugs are developed in the United States. Why? Because there's money in it. As if that were a bad thing ...

Despite advancements in modern medicine, leprosy remains a persistent public health challenge, particularly in developing nations. The implementation of new ...

The US Food and Drug Administration (FDA) has issued draft guidance on developing cancer drugs intended for use in combination with other therapies. The guidance focuses on demonstrating each drug's ...

Researchers at the University of British Columbia and BC Cancer have developed a new way to target proteins long considered ...